GenMark Diagnostics (GNMK) Tops Q4 EPS by 6c

GenMark Diagnostics (NASDAQ: GNMK) reported Q4 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $12.3 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Aptera Motors (SEV) Reports Q2 Loss of $0.20
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance